PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis

It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vella, Veronica, Nicolosi, Maria Luisa, Giuliano, Stefania, Bellomo, Maria, Belfiore, Antonino, Malaguarnera, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319972/
https://www.ncbi.nlm.nih.gov/pubmed/28275367
http://dx.doi.org/10.3389/fendo.2017.00031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319972/
https://www.ncbi.nlm.nih.gov/pubmed/28275367
http://dx.doi.org/10.3389/fendo.2017.00031

Ejemplares similares